50 /100
MEDIUM RISK
Score updated May 30, 2026

KPRX — Kiora Pharmaceuticals, Inc. Dilution Risk Tracker

Track KPRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track KPRX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
27
⚠️ Warrant Exposure
90
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
42%
📜 Warrant Exercise 60%
• Massive warrant overhang: 124% of shares outstanding
• Warrant risk score very high (90/100)
📉 Score Deterioration 40%
• Score rose 30 points recently (worsening)
🔔 Track KPRX — Get forecast alerts →

💹 Market Data

Market Cap$11.88M
Shares Outstanding4.43M
Float4.30M
Cash$13.87M
Debt$373.6K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 42.2% shares (2025Q4 vs prior)
19 institutional holders · 875.9K shares
#1 ADAR1 Capital Management, LLC 335.9K shares
#2 Stonepine Capital Management, LLC 131.1K shares
#3 DRW Securities, LLC 110.3K shares
+ 16 more holders Sign up free to view →

📉 Short Interest

Short Interest22.0K
Days to Cover1.0
% of Float0.5%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2023
8-K 8K EVENT Apr 07, 2026
4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Apr 02, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track KPRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking KPRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for KPRX
📊 KPRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 KPRX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.